Literature DB >> 7395966

Galactosamine-induced cell death in primary cultures of rat hepatocytes.

F A Schanne, R G Pfau, J L Farber.   

Abstract

Primary cultures of rat hepatocytes were exposed to 0.5 mM D-galactosamine. After 36 hours, only 10-20% of the original cells were viable, as assessed by trypan blue exclusion. In the absence of galactosamine, there was no loss of viability over this same period. The addition of 3 mM uridine to the culture medium completely prevented the cell death produced by galactosamine. Glucosamine had no effect on the viability of the hepatocytes. The extent of galactosamine-induced cell death was dependent upon the concentration of Ca++ ions in the culture medium. With the only source of Ca++ that added with the fetal calf serum, galactosamine had only a very slight effect on viability. With higher Ca++ than with the fetal calf serum, galactosamine had only a very slight effect on viability. With higher Ca++ concentrations, from 0.9 to 3.6 mM, the viability ranged from 75% to 31% 18 hours after treatment with galactosamine. The addition of 1.4 microM chlorpromazine to culture medium containing 1.8 mM Ca++ decreased the extent of the galactosamine-induced cell death. This protective effect was progressively reduced by raising the Ca++ concentration to 3.6 and 5.4 mM. Chlorpromazine given to intact rats 2 hours after treatment with 400 mg/kg galactosamine prevented the appearance of liver cell necrosis. At the same time, chlorpromazine prevented the increases in liver cell Ca++ content. These results indicate that many of the features of the effect of galactosamine on intact rat liver cells can be reproduced in primary cultures of these same cells. The data also support the hypothesis that a disturbance in intracellular Ca++ homeostasis leading to accumulations of these ions is causally related to the cell death produced by galactosamine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7395966      PMCID: PMC1903781     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  The disruption of immunoglobulin caps by local anesthetics.

Authors:  G F Schreiner; E R Unanue
Journal:  Clin Immunol Immunopathol       Date:  1976-09

2.  Biochemical changes in liver in acute thioacetamide intoxication.

Authors:  C H GALLAGHER; D N GUPTA; J D JUDAH; K R REES
Journal:  J Pathol Bacteriol       Date:  1956-07

3.  Effects of membrane stabilizers on pancreatic amylase release.

Authors:  J A Williams; J H Poulsen; M Lee
Journal:  J Membr Biol       Date:  1977-05-06       Impact factor: 1.843

4.  Influence of liver-RES on toxic liver damage due to galactosamine.

Authors:  M Grün; H Liehr; W Grün; U Rasenack; D Brunswig
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1974-02

5.  Calcium reversal of nerve blockade by alcohols, anesthetics, tranquilizers, and barbiturates.

Authors:  P Seeman; S S Chen; M Chau-Wong; A Staiman
Journal:  Can J Physiol Pharmacol       Date:  1974-06       Impact factor: 2.273

6.  Experimental hepatitis induced by D-galactosamine.

Authors:  D Keppler; R Lesch; W Reutter; K Decker
Journal:  Exp Mol Pathol       Date:  1968-10       Impact factor: 3.362

7.  Calcium uptake of a rat liver microsomal subcellular fraction in response to in vivo administration of carbon tetrachloride.

Authors:  L Moore; G Rodman Davenport; E J Landon
Journal:  J Biol Chem       Date:  1976-02-25       Impact factor: 5.157

8.  Prevention of galactosamine-induced liver cell necrosis by uridine.

Authors:  J L Farber; G Gill; Y Konishi
Journal:  Am J Pathol       Date:  1973-07       Impact factor: 4.307

9.  Calcium dependence of toxic cell death: a final common pathway.

Authors:  F A Schanne; A B Kane; E E Young; J L Farber
Journal:  Science       Date:  1979-11-09       Impact factor: 47.728

10.  LIVER PARENCHYMAL CELL INJURY. I. INITIAL ALTERATIONS OF THE CELL FOLLOWING POISONING WITH CARBON TETRACHLORIDE.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-10       Impact factor: 10.539

View more
  11 in total

1.  Ultrastruct pathology of phalloidin-intoxicated hepatocytes in the presence and absence of extracellular calcium.

Authors:  M A Russo; A B Kane; J L Farber
Journal:  Am J Pathol       Date:  1982-11       Impact factor: 4.307

2.  Liver calcium and endotoxin action.

Authors:  M M Fritz; D O Keppler
Journal:  Naturwissenschaften       Date:  1982-03

3.  Targeted protection of hepatocytes from galactosamine toxicity in vivo.

Authors:  V Keegan-Rogers; G Y Wu
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Changes in free radicals, trace elements, and neurophysiological function in rats with liver damage induced by D-galactosamine.

Authors:  H L Hu; R D Chen
Journal:  Biol Trace Elem Res       Date:  1992-07       Impact factor: 3.738

5.  Dependence of the carbon-tetrachloride--induced death of cultured hepatocytes on the extracellular calcium concentration.

Authors:  A F Casini; J L Farber
Journal:  Am J Pathol       Date:  1981-11       Impact factor: 4.307

Review 6.  Myocardial ischemia: the pathogenesis of irreversible cell injury in ischemia.

Authors:  J L Farber; K R Chien; S Mittnacht
Journal:  Am J Pathol       Date:  1981-02       Impact factor: 4.307

7.  An ultrastructural and histochemical study of the prominent inflammatory response in D(+)-galactosamine hepatotoxicity.

Authors:  J R MacDonald; J H Beckstead; E A Smuckler
Journal:  Br J Exp Pathol       Date:  1987-04

8.  Kinetics of cell death induced in 10T1/2 cells by methyl methanesulfonate and the effects of extracellular calcium on cell death.

Authors:  G J Smith; J W Grisham; M M Fatteh
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

9.  Effects of oral agents on pancreatic duct permeability. A model of acute alcoholic pancreatitis.

Authors:  K R Wedgwood; G Adler; H Kern; H A Reber
Journal:  Dig Dis Sci       Date:  1986-10       Impact factor: 3.199

Review 10.  The role of calcium ions in toxic cell injury.

Authors:  J L Farber
Journal:  Environ Health Perspect       Date:  1990-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.